Loading company…
NASAL PHYTO develops nasal drug delivery technology and drug candidates for central nervous system diseases.
Founded in 2019 and based in Shenzhen, China, NASAL PHYTO develops drugs for central nervous system diseases and nasal delivery systems. Its products and candidates include Nasal-TDI and NPRD001 through NPRD004, targeting conditions including Parkinson's disease, depression, stroke and cancer. The company raised Series A funding in September 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in